Among the available tumour markers, carcinoembryonic antigen (CEA), carbohydrate antigen (CA)19-9, and CA72-4 are widely used for the follow-up of patients with gastrointestinal malignancies 22, 23; however, these methods lack specificity. The gene discussed is CEACAM5; the disease is neoplasm.